Drug profile · INN
cysteamine bitartrate
CYSTAGON
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
cysteamine bitartrate (CYSTAGON) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN cysteamine bitartrate
Brand CYSTAGON
Route ORAL
Formulation GRANULE, DELAYED RELEASE
Frequently asked questions
What is cysteamine bitartrate?
cysteamine bitartrate (CYSTAGON) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cysteamine bitartrate?
CYSTAGON is a marketed brand name for cysteamine bitartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cysteamine bitartrate?
cysteamine bitartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.